Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum DionyMed Brands Inc (Sub Voting) DYMEF

Healthcare Drug Manufacturers - Major
DionyMed Brands Inc is a multi-state cannabis brand and distribution platform based in Canada. The company provides support to cultivators and manufacturers of medical and adult-use cannabis products. It sells branded products in every category from flower to vape cartridges, concentrates, and edibles. Geographically, it derives a majority revenue from the United States of America. The company... see more

GREY:DYMEF - Post Discussion

DionyMed Brands Inc (Sub Voting) > Lack of Interest
View:
Post by BenjaminGraham2 on Jun 26, 2019 1:49pm

Lack of Interest

I am perplexed that there is no buying interest down at these levels. The company did US$14mm of rev in Q1, aiming to do US$11m in Q2 and hopefully Q3 reflects greater distribtuion in LA, Sacremnto and the additional brands they acquired. Management needs to do a better job at promoting this to new investors.
Comment by Omegaa on Jun 27, 2019 7:58pm
Why would they be aiming for 11m in Q2 if  revenues in Q1 were 14m? Any reason for the inconsistent numbers?
Comment by STOCKRUS on Jul 03, 2019 11:50pm
Yes it's unfortunate with DYME.V ...... I was looking towards a good 2019 .......  I sold my shares 2 months ago for $2.50 ..... You may want to take a look at this junior producer that is under the radar. I bought in at 50-60 cents and I'm looking at $1.00-$2.00. Here's the latest news. Signs JV with China Pharma - Zhejiang Yatai Pharmaceutical  Completes ...more  
DionyMed Brands Inc (Sub Voting)